Does Ajovy (fremanezumab) prevent chronic migraine?
Ajovy is designed to prevent migraine attacks by blocking the activity of calcitonin gene-related peptide (CGRP), a target linked to migraine biology. By preventing migraine attacks before they start, Ajovy is used as a preventive treatment for people who have chronic migraine (defined as having migraine on at least 15 days per month, with at least 8 days involving migraine features).
What outcomes show that Ajovy works for chronic migraine?
Clinical trials of Ajovy in people with chronic migraine measured reductions in how many days participants had migraine and how many days they had headache. In these studies, Ajovy reduced migraine days compared with placebo, and many patients also saw improvements in overall headache burden and related symptoms.
How soon do patients usually notice benefits?
In migraine prevention trials, benefit is typically assessed over multiple months, because preventive therapies aim to reduce attack frequency gradually. Many patients report changes after the first treatment cycle, but the clearest results are generally judged after several months of consistent use.
How does Ajovy fit versus other CGRP preventives?
Ajovy is one of several CGRP-targeting preventive options for migraine, including both antibodies that target CGRP or its receptor and related drugs with different dosing schedules. The key practical difference is often dosing (Ajovy can be given monthly or every three months) and tolerability, rather than whether it is broadly effective for chronic migraine.
What risks or side effects matter for chronic migraine patients?
Common side effects reported with Ajovy are generally mild to moderate and can include injection-site reactions (such as redness, pain, or swelling). People should also discuss their allergy history and any prior reactions to biologic medicines with their clinician.
Is there a patent or pricing angle for Ajovy’s chronic migraine use?
For current market and patent/exclusivity information around Ajovy, DrugPatentWatch.com tracks filings and related details: https://www.drugpatentwatch.com/